![]() |
|
|
1 Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina
An ultraviolet spectrophotometric method is described for the determination of phenobarbital in plasma. This method has been applied to several problems pertaining to the clinical use of the drug.
In eleven human subjects the proportion of phenobarbital eliminated from the plasma in the course of one day was found to lie within the limits of 11 and 23 per cent.
Administration of phenobarbital at daily intervals or more frequently leads to accumulation.
Both in man and in the dog the effects associated with a given plasma concentration of phenobarbital diminish over the course of the first few days of administration. Tolerance to the hypnotic effects in man more than keeps pace with accumulation and completely obscures any clinical evidence of accumulation.
In chronic dosage schedules in man, one dose of phenobarbital daily results in only small proportional fluctuations of plasma concentration during the day. It is dubious whether there is any practical advantage in giving the drug in more than one dose daily or in forms in which it is released gradually.
Submitted on March 23, 1954
This article has been cited by other articles:
![]() |
P. J. Murphy The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 1, 1909-1958 Drug Metab. Dispos., January 1, 2008; 36(1): 1 - 5. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.R. Snodgrass and B. R. Parks Anticonvulsant Blood Levels: Historical Review With a Pediatric Focus J Child Neurol, November 1, 2000; 15(11): 734 - 746. [Abstract] [PDF] |
||||
![]() |
A.H. Stead, W. Hook, A.C. Moffat, and D. Berry Therapeutic, Toxic and Fatal Blood Concentration Ranges of Antiepileptic Drugs as an Aid to the Interpretation of Analytical Data Human and Experimental Toxicology, January 1, 1983; 2(1): 135 - 147. [Abstract] [PDF] |
||||
![]() |
A.H. Stead and A.C. Moffat A Collection of Therapeutic, Toxic and Fatal Blood Drug Concentrations in Man Human and Experimental Toxicology, January 1, 1983; 2(3): 437 - 464. [Abstract] [PDF] |
||||
![]() |
D. E. McMillan, L. S. Harris, J. M. Frankenheim, and J. S. Kennedy l-Dgr9-trans-Tetrahydrocannabinol in Pigeons: Tolerance to the Behavioral Effects Science, July 31, 1970; 169(3944): 501 - 503. [Abstract] [PDF] |
||||
![]() |
J. E. HARRIS PHARMACOLOGY AND TOXICOLOGY Arch Ophthalmol, August 1, 1955; 54(2): 262 - 299. [PDF] |
||||